Disarming pathogens--a new approach for antibiotic development.
Waldor
Matthew K
MK
Department of Microbiology, Tufts University School of Medicine, Boston, USA.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002087:Butyrates / Q000494:pharmacology*; D002772:Cholera Toxin / Q000096:biosynthesis / Q000235:genetics; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D007421:Intestine, Small / Q000382:microbiology; D051379:Mice; D009281:Naphthalenes / Q000494:pharmacology*; D053644:Naphthalimides; D014157:Transcription Factors / Q000096:biosynthesis; D014734:Vibrio cholerae / Q000187:drug effects* / Q000472:pathogenicity; D014774:Virulence / Q000187:drug effects; D037521:Virulence Factors / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002087:Butyrates; D009281:Naphthalenes; D053644:Naphthalimides; D014157:Transcription Factors; D037521:Virulence Factors; C505381:virstatin; C075626:tcpN protein, Vibrio cholerae; D002772:Cholera Toxin